Li Qin

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

High Throughput

Tyrosine Kinase

Breast Cancer Cells

Top Venues

Communications biology

Endocrine-related cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yosi Gilad, Yossi Eliaz, Yang Yu, Adam M Dean, Sang Jun Han, Li Qin, Bert W O' Malley, David M Lonard
Reply to: Target expression is a relevant factor in synthetic lethal screens. Communications biology 5 (1) (2022)
Li Qin, Jianwei Chen, Dong Lu, Prashi Jain, Yang Yu, David Cardenas, Xiaohui Peng, Xiaobin Yu, Jianming Xu, Jin Wang, Bert W O'Malley, David M Lonard
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocrine-related cancer 28 (10) (2021)
Yosi Gilad, Yossi Eliaz, Yang Yu, Adam M Dean, Sang Jun Han, Li Qin, Bert W O' Malley, David M Lonard
A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells. Communications biology 4 (1) (2021)